West Pharmaceutical Services (WST) has come under significant public scrutiny and legal investigation due to possible securities fraud. Numerous law firms, such as ROSEN, Levi & Korsinsky, Faruqi & Faruqi, and the Law Offices of Frank R. Cruz, have filed class action lawsuits against WST on behalf of its investors. Their aim is to compensate those, who may have suffered financial losses due to misleading information provided by the company about its financial status. Encouragements have been made for shareholders to join these class action lawsuits to maximize their potential compensation. On a positive note, WST has revealed some buoyant financial data. It has announced recent leadership changes and showed a positive trend in financial performance reports, including second, third, fourth quarter and full-year results, as well as an increased fiscal year guidance. The company also announced a collaboration with Corning on pharmaceutical injectable drug delivery.
West Pharmaceutical Services WST News Analytics from Tue, 25 Jan 2022 08:00:00 GMT to Sat, 17 May 2025 22:43:12 GMT - Rating -6 - Innovation 0 - Information 5 - Rumor -2
